MGMT
MGMT (O-6-methylguanine-DNA methyltransferase) is a nuclear DNA repair protein that defends cells against the mutagenic and toxic effects of alkylating agents. It removes methyl groups from damaged DNA bases by transferring them to itself, in a single-use reaction. Browse Assay Genie's current range of MGMT research reagents below, or read on for the biology behind the target.
MGMT is involved in the cellular defence against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. It repairs the methylated nucleobase by stoichiometrically transferring the methyl group to a cysteine residue within the enzyme itself. This is a suicide reaction: each MGMT molecule is irreversibly inactivated after one repair event, so repair capacity depends on how much active protein a cell holds. The enzyme also acts on O(6)-alkylguanine and other methylated moieties in DNA, removing lesions that would otherwise be toxic or mutagenic.
The MGMT gene encodes a protein that localises to the nucleus, where it can act on DNA. UniProt classifies it in the MGMT family, and HGNC places the gene within the DNA/RNA methyltransferases group and the methyltransferases with unique structures. The enzyme is catalogued as EC 2.1.1.63, and the UniProt protein name is methylated-DNA--protein-cysteine methyltransferase. Mouse and rat each carry an orthologous Mgmt gene, so the biology can be studied in common rodent models.
Alkylating agents are potent carcinogens that can cause cell death, mutation and cancer, and MGMT protects against both mutagenesis and toxicity from these agents. Methylation of the MGMT promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. For this reason, researchers studying the MGMT gene and its protein product often look at both enzyme expression and promoter methylation status when investigating alkylation damage and its consequences.
MGMT directly reverses O6-methylguanine and O4-methylthymine lesions, making it a central protein for studying defence against alkylation damage.
The protein protects cells from mutagenesis and toxicity caused by alkylating agents, which can lead to cell death, mutation and cancer.
Promoter methylation of the MGMT gene is associated with colorectal cancer, lung cancer, lymphoma and glioblastoma.
Stoichiometric methyl transfer to an internal cysteine irreversibly inactivates MGMT, a useful model for single-turnover repair.
MGMT repairs O6-methylguanine and O4-methylthymine lesions in DNA. It transfers the methyl group to a cysteine residue in its own sequence. The reaction is stoichiometric and irreversible, so the enzyme is inactivated after one repair event, which is why it is described as a suicide enzyme.
The HGNC symbol is MGMT and the approved name is O-6-methylguanine-DNA methyltransferase. UniProt uses the protein name methylated-DNA--protein-cysteine methyltransferase, and the enzyme carries the EC number 2.1.1.63. No alternative gene symbols or previous names are recorded in HGNC.
Methylation of the MGMT promoter has been associated with colorectal cancer, lung cancer, lymphoma and glioblastoma. Mouse and rat both have an orthologous Mgmt gene. Check the datasheet of any product for its validated reactivity.
Other DNA repair proteins, methyltransferases and cancer-associated markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P16455; product specifications from Assay Genie datasheets.